2m 2m 2m 2m 2m 2m 2m
Myriad Genetics (MYGN)
NASDAQ
$4.63+$0.13 (+2.89%)
Price as of Jun 23, 2026 5:18 PM EDT- $425.0MMarket Cap
- -7.41%1-Year Change
- Diagnostics & ResearchIndustry
Myriad Genetics (MYGN)
$4.63+$0.13 (+2.89%)
MYGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.50 | ||
Change | -$0.04 (-0.88%) | ||
Open | $4.54 | ||
High | $4.62 | ||
Low | $4.42 | ||
Previous Close | $4.54 | ||
Volume | 1,271,242 | ||
30-Day Average Volume | 1,707,896 | ||
1-Week Change | 4.17% | ||
1-Month Change | 17.80% | ||
1-Year Change | -7.41% | ||
3-Year Change | -80.47% | ||
5-Year Change | -84.94% | ||
Fundamentals | |||
Shares Outstanding | 94.4M | ||
Total Assets | $673.7M | ||
Market Cap | $425.0M | ||
Enterprise Value | $420.9M | ||
Period: QTR TTM FY | |||
Revenue | $200.4M | ||
Net Income | -$34.1M | ||
Free Cash Flow | -$15.7M | ||
EBIT | -$34.1M | ||
EBITDA | -$21.6M | ||
Net Working Capital | $182.6M | ||
EPS | -$0.36 | ||
Enterprise Value/EBITDA | -19 | ||
Enterprise Value/Revenue | 2 | ||
P/B | 1 | ||
P/E | -13 | ||
PEG | 0 | ||
Price/Free Cash Flow | -27 | ||
Price/Operating Cash Flow | -27 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 03/26/2009 | ||
Earnings & Revenue